Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Ulcerative Colitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02734589
What this trial is testing

Fecal Transplantation Using a Diet for Donor and Recipient in Refractory Colitis

Who this might be right for
Ulcerative Colitis
Wolfson Medical Center 54
Testing effectiveness (Phase 2)Ended earlyNCT00583531
What this trial is testing

Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis

Who this might be right for
Pouchitis
Ocera Therapeutics 2
Very early researchUnknownNCT05239702
What this trial is testing

Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases

Who this might be right for
Crohn DiseaseUlcerative ColitisDermatomyositis+2 more
Zhejiang University 75
Large-scale testing (Phase 3)Ended earlyNCT02142725
What this trial is testing

Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Dr. Falk Pharma GmbH 468
Large-scale testing (Phase 3)Study completedNCT00347048
What this trial is testing

Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients

Who this might be right for
Ulcerative Colitis
Astellas Pharma Inc 62
Large-scale testing (Phase 3)Study completedNCT00643071
What this trial is testing

Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients

Who this might be right for
Ulcerative Colitis
Astellas Pharma Inc 32
Testing effectiveness (Phase 2)Study completedNCT03760003
What this trial is testing

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abivax S.A. 355
Post-approval studies (Phase 4)Study completedNCT01481142
What this trial is testing

Adacolumn in Refractory UC Patients Trial

Who this might be right for
Ulcerative Colitis, Active Moderate
Otsuka Pharmaceutical Europe Ltd 100
Very early researchStudy completedNCT03268213
What this trial is testing

Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis

Who this might be right for
Clostridium Difficile InfectionUlcerative ColitisIndeterminate Colitis
Stony Brook University 12
Very early researchLooking for participantsNCT07435779
What this trial is testing

Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study

Who this might be right for
UC
Hebei Senlang Biotechnology Inc., Ltd. 12
Not applicableLooking for participantsNCT07198113
What this trial is testing

COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)

Who this might be right for
Ulcerative Colitis, PediatricInflammatory Bowel DiseasesCrohn Disease
University of North Carolina, Chapel Hill 1,100
Large-scale testing (Phase 3)Ended earlyNCT00279435
What this trial is testing

Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study

Who this might be right for
Ulcerative Colitis
Facet Biotech 25
Testing effectiveness (Phase 2)UnknownNCT01011322
What this trial is testing

Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis

Who this might be right for
Ulcerative ColitisLarge IntestineDiarrhea+1 more
Lipid Therapeutics GmbH 156
Testing effectiveness (Phase 2)Study completedNCT03093259
What this trial is testing

ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abivax S.A. 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07297069
What this trial is testing

Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO Trial

Who this might be right for
Acute Severe Ulcerative Colitis
Asian Institute of Gastroenterology, India 60
Large-scale testing (Phase 3)Looking for participantsNCT06660693
What this trial is testing

Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
McMaster University 134
Large-scale testing (Phase 3)Study completedNCT01493960
What this trial is testing

The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patients

Who this might be right for
Colitis, Ulcerative
InDex Pharmaceuticals 131
Not applicableUnknownNCT05430412
What this trial is testing

CT to Assess the Efficacy and Safety of Adding GMA to Infliximab in Paediatric Patients With Steroid-refractory Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Adacyte Therapeutics SL 15
Not applicableEnded earlyNCT00355901
What this trial is testing

An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
PDL BioPharma, Inc. 300
Large-scale testing (Phase 3)Study completedNCT00032305
What this trial is testing

Research Study in Patients With Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Facet Biotech 20
Next Page